Collaboration will couple NIA Magellan’s robust infrastructure with InformedDNA’s clinical genetics expertise and national provider network

Magellan Health, Inc. (NASDAQ: MGLN) today announced that NIA Magellan, which offers a suite of specialty solutions to address many complex areas of healthcare, will collaborate with InformedDNA to offer an evidence-based genetic benefits optimization program. InformedDNA’s national network of independent board-certified genetics specialists provides expert clinical review services to ensure appropriate use of genetic testing and improve patient care, while at the same time delivering significant cost savings.

With rapid growth in the number of new genetic tests being brought to market, and the high rate of inappropriate ordering, this collaboration provides a critical solution by offering genetic testing guidance by independent genetics specialists to patients and physicians alike. This approach has been proven to deliver high-quality, cost-effective and clinically actionable genetic testing.

“Advances in genetic testing are at the forefront of personalized healthcare, enabling individuals to make informed choices about their healthcare,” said Tina M. Blasi, chief executive officer of NIA Magellan. “With those advancements, however, we must also ensure we are diligently monitoring the clinical appropriateness of genetic testing, and most importantly, that we are providing the genetic counseling and information necessary for individuals to best understand the results and any subsequent care that may be needed. Collaborating with InformedDNA will provide our customers and their members with genetics expertise, that when coupled with NIA Magellan’s existing infrastructure and clinical leadership, will help to improve care and avoid unnecessary and costly tests. I’m excited about offering this cutting-edge capability.”

“As the premier genetic benefits management organization, deploying InformedDNA’s genetics expertise within NIA Magellan's established technology infrastructure allows InformedDNA to continue our rapid growth with health plan customers of all sizes,” stated InformedDNA chief executive officer David Nixon. “Personalized medicine will continue to be one of the most powerful trends in healthcare for years to come. Collaborating with NIA Magellan positions us to expand delivery of our highly successful patient-centric approach that improves care while optimizing costs," Nixon concluded.

NIA Magellan’s suite of specialty solutions includes diagnostic imaging management services, as well as programs that manage the evaluation and therapy associated with cardiology services, musculoskeletal management, radiation oncology, obstetrical ultrasounds, and sleep management.

InformedDNA empowers personalized healthcare by providing genetics expertise to health plans, decision support to providers and expert genetic counseling services to patients.

About Magellan Health: Headquartered in Scottsdale, Ariz., Magellan Health, Inc. is a healthcare management company that focuses on fast-growing, complex and high-cost areas of healthcare, with an emphasis on special population management. Magellan delivers innovative solutions to improve quality outcomes and optimize the cost of care for those we serve. Magellan’s customers include health plans, managed care organizations, insurance companies, employers, labor unions, various military and government agencies, third party administrators, consultants and brokers. For more information, visit MagellanHealth.com.

About InformedDNA: InformedDNA helps individuals and healthcare providers accurately interpret family health history and genetics, bringing the promise of personalized healthcare to life. InformedDNA is the authority on the appropriate use of genetic testing – leveraging the expertise of the largest network of independent genetics specialists to help ensure health plans, hospitals, employers, community clinicians and patients all have access to the highest quality genetic services. InformedDNA's key offerings include clinical genetic counseling, genetic testing utilization management, and personalized hereditary risk assessment and prevention solutions. For more information, visit www.informeddna.com.

Magellan Health, Inc.Media Contact:Colleen Flanagan Johnson, 860-507-1923cefjohnson@magellanhealth.comorInvestor Contact:Renie Shapiro Silver, 877-645-6464rshapiro@magellanhealth.com

Magellan Health (NASDAQ:MGLN)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Magellan Health Charts.
Magellan Health (NASDAQ:MGLN)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Magellan Health Charts.